Ingeborg S Aaberge

Title: Ingeborg S Aaberge: Innovator in Vaccine Development

Introduction

Ingeborg S Aaberge is a notable inventor based in Oslo, Norway. She has made significant contributions to the field of vaccine development, particularly in the area of combination vaccines. Her work has implications for treating and preventing infections, showcasing her dedication to public health.

Latest Patents

Ingeborg S Aaberge holds one patent that focuses on combination vaccines. This patent describes vaccines that include serogroup B proteoliposomic vesicles and serogroup C conjugated oligosaccharides. Her innovative approach aims to enhance the effectiveness of vaccines in combating infectious diseases.

Career Highlights

Throughout her career, Aaberge has worked with prominent organizations such as Novartis AG and the Norwegian Institute of Public Health. Her experience in these institutions has allowed her to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Ingeborg S Aaberge has collaborated with esteemed colleagues, including Dan M Granoff and Howard V Raff. These partnerships have further enriched her research and have played a crucial role in advancing her work in vaccine technology.

Conclusion

Ingeborg S Aaberge's contributions to vaccine development highlight her innovative spirit and commitment to improving public health. Her work continues to inspire future advancements in the field of immunology.